CPHI Milan Pharma Awards 2026 Finalists Announced
Informa Markets reveals CPHI Pharma Awards 2026 finalists across 15 categories, celebrating innovation in drug development, digital transformation, and sustainability.

Milan, Italy - September 1st, 2026 - Informa Markets has today announced the finalists for the CPHI Pharma Awards 2026, recognising outstanding achievements across companies and individuals pushing the boundaries of science and technology to advance global healthcare.
The CPHI Pharma Awards shortlist for 2026 celebrates 15 categories, spotlighting individuals and companies in drug development, digital transformation, supply chain, manufacturing, sustainability, partnerships and leadership.
Tara Dougal, CPHI Event Director, Informa Markets said: “We’ve been incredibly impressed by the quality, originality, and ambition of this year’s submissions. Across every category, the finalists are setting new standards across the board. The CPHI Pharma Awards are a vital platform to spotlight the progress shaping the future of our industry, and we’re looking forward to celebrating these achievements and announcing the winners on the opening day of CPHI Milan.”
The winners will be revealed during a networking reception on October 6 – the opening day of CPHI Milan, which runs from October 6-8.
Finalists by Category
The full list of 2026 finalists is available by category below. Further information on each finalist can be found:
API Development and Innovation
MODAG: Combined neurodegeneration platform involving PD DETECT® and Emrusolmin
Lonza: GlycoConnect® dual-payload antibody-drug conjugate technology
Cambrex: Automated liquid-phase peptide synthesis platform
FUJIFILM Biotechnologies: ShunzymeX™
Digital Transformation
4G Clinical: Digital Clinical Supply Chain Control for Complex Trials
Evonik Industries: Self-driving labs
ForgeStop: ForgeStop Connected Products Platform — NFC Authentication for Pharmaceutical Supply Chains
Adalvo: Intelligence at Scale: How Adalvo Built an Enterprise-Grade Digital Transformation Engine at the Heart of a Specialist B2B Pharma Business
Peerox: MADDOX: AI-Driven Knowledge & Troubleshooting Layer Empowering Shopfloor Operators in Pharma Packaging
Catalent: Qai™ Deviation Manager: AI-Enabled Digital Quality Transformation at Enterprise Scale.
Innovation in Drug Delivery, Devices and Packaging
NVV Pharma: ClearliQ Earwax: A Biomintetic Cerumenolytic Medical Device for Safe Self-Care of Earwax Impaction
Eco-Inject: Eco-inject Sustainable Autoinjector
LTS-Lohmann Therapie-System: LTS AccuTip Microneedle Array Patch Platform
Palladio Group: Smart Pill Pocket
ForgeStop:× EM Microelectronic - Secure Connected Packaging for Pharmaceutical Track-and-Trace and Authentication.
Excellence with Purpose
Kepler Healthcare: Welcome Girl - A lifelong Noble Initiative” by Kepler Healthcare
Strides Pharma Science: Learn While You Earn programme
Medical & Pharmaceutical Industry Development Agency of Uzbekistan: Making medicines affordable in Uzbekistan: Reference Pricing, Digital Monitoring and Public Access
Urtica: Named patient import when every dose matters
Accord Healthcare: Hetronifly® (Serplulimab): Expanding Equitable Access to Immunotherapy Through Purpose Driven Collaboration.
Finished Formulation
Cor.Con International: Epilamba Junior
Santa Farma: Innovative Mirabegron Modified-Release Formulation Platform for First-Generic Overactive Bladder Therapies
SeraNovo: NanoGlass™, a formulation platform for oral BCS IV and bRo5 drugs
Ashland: Permexa™ sodium caprate.
Innovation Catalyst
IMA SpA: ASSEMBLA – A Scalable, Device-Centric Assembly Platform Enabling End-to-End Medical Device Industrialisation
FUJIFILM Biotechnologies: MaruX
Prolific Machines: Optogenetic Platform Achieves Record-Breaking 21 g/L Antibody Titer
StablePharma: StablevaX®: Catalysing an Ecosystem of Thermostable Medicines
Aizon: Operational foundation for GMP AI
Touchlight: Cell-free Doggybone™ DNA (dbDNA™) platform
VeriSIM Life: VeriSIM Life.
Manufacturing Excellence
Anemocyte: AMCAP enzymatic mRNA manufacturing technology: Manufacturing technology
IMA SpA’s DOMINA: DOMINA - Master of tabletting platform
Lyo Innovation: LyoinMSTrack® Mass Spectrometry
Bespak Bio: Next-Generation Gene Therapy Manufacturing Technology
Touchlight: World's First GMP-Licensed Cell-Free DNA Facility.
Supply Chain Excellence
Cryoport Systems: Defining Pharmaceutical Supply Chain Excellence Through ISO 21973 Certification
Adalvo: From Reactive to Resilient: How Adalvo Rebuilt Supply Chain Planning as a Strategic Advantage
LSPedia: LSPedia OneScan
Occam Systems: The Data-Driven Strategic Supply Chain Advantage
Almac Group: Adapt™ platform: Zero Margin for Error: Supply Chain Excellence in Ultra-Rare Gene Therapy with Almac Adapt™
Sustainable Pharma Excellence
Nordic Bioproducts Group: AaltoCell®: Transforming Pharmaceutical Manufacturing Through Sustainable High-Performance MCC
Bloomage Biotechnology: Bloomsac™ Sodium Chondroitin Sulfate
SCHOTT Pharma: Circular packaging – Delivery of pharmaceutical vials in circular packaging
Celtic Renewables: Leading the green chemical revolution
SK Pharmteco: Transforming Solvent Sustainability in Pharmaceutical Manufacturing through a Data-Driven Framework and Circular Acetonitrile Recovery
Sunresin New Materials: Uniform Functionalized Polymer Resin Technology: Redefining the Concept of Sustainability in Peptide Manufacturing
Touchlight: World's First GMP-Licensed Cell-Free DNA Facility: Repurposed Infrastructure and Smaller Manufacturing Footprint.
Sustainable Transformation Partnership
Sartorius: From Suppliers to End Users: Creating a Cross-Industry Partnership for Circular Bioprocessing
AstraZeneca: Further Together: Partnering for Systemic Change
Pharmaceutical Supply Chain Initiative: Lead with Purpose, Decarbonize Faster - The PSCI Decarbonization Summit
Schneider Electric: Pharma collaboration driving supply chain decarbonization
True Partnership Excellence
CMAC: A world-leading manufacturing research consortium spanning academic and industry partners
MedPharm: Advancing First-in-Disease Topical Therapies Through Strategic Partnership: MedPharm and Palvella’s Co-Development of QTORIN™ Rapamycin from Concept to Commercial Readiness
Enzene: From At‑Risk to Accelerated: How Enzene Redefines Biologics Development
Adalvo: More Than a Dossier: How Adalvo Builds True Partnerships on Shared Risk, Shared Reward, and Shared Mission
Santa Farma: Transforming of Complex Local Generics into Global Patient Access
Aurigene Pharmaceutical Services: Zoliflodacin End-to-End Multiparty Partnership.
Start-up Initiative
SolasCure: Aurase Wound Gel
NVV Pharma: ClearliQ: How a Dutch SME Disrupted Decades-Old Earwax Care with Biosolvent Science
Eco-Inject: Eco-Inject Sustainable Autoinjector
Lambda Biologics: ODISEI - The Organoid-based Discovery Platform for Innovative Screening, Evaluation, and Identification
Primogene: Primogene – Cell-Free Enzymatic Biomanufacturing Platform
RAWGA: VC-H1(Plant-based collagen alternative).
Future Leader
Dr Steven Nicholson of Crystec
Jakub Knurek of Mabion
Milena Gonakova of Pfizer CentreOne
Dr Sean McMahon of Ashland
Dr Pauline van der Wijst-Janssen of DFE Pharma.
Woman of the Year
Emma Charles of Bristol Myers Squibb
Jennifer Gattari of Pfizer CentreOne
Lorna Murtagh of Pfizer CentreOne
Maja Pedersen of FUJIFILM Biotechnologies
Martina Feitzinger of Adalvo
Zhao Yan of Bloomage Biotechnology
CEO of the Year
Anil Okay of Adalvo
Joerg Ahlgrimm of SK Pharmteco
Julia Tsetis of Tsetis Group
Prashant Nagre of Fermenta Biotech
Shreehas Tambe of Biocon
Swapn Malpani of Cipla
Michael Kocher of Xellia Pharmaceuticals
Zhao Yan of Bloomage Biotechnology.
This year’s awards are sponsored by IQVIA, a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries; Industrial Technology Research Institute (ITRI); and Taiwan Pharmaceutical Alliance.
The CPHI Pharma Awards event is open to all at CPHI Milan. Register to attend the show here.
Reporting on the science, business and regulation shaping the pharmaceutical industry.
More from Pharma News
All stories →
Pharming Group Gains FDA Approval for Leniolisib in Children Aged 4–11 with APDS

Lonza Builds Oregon Spray-Drying Facility To Expand SDD Capacity

Discussion